Clinical trials sponsored by Jacobio Pharmaceuticals Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Jacobio Pharmaceuticals Co., Ltd.

• A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
  NCT06959615 · Phase: Phase 1, Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 64 locations
• JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
  NCT06973564 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
  NCT05490472 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
  NCT07640295 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations

Common questions

How many trials is Jacobio Pharmaceuticals Co., Ltd. recruiting for?

Jacobio Pharmaceuticals Co., Ltd. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.